Amuvatinib
-
Catalog number9458-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameN-(Benzo[d][1,3]dioxol-5-ylmethyl)-4-(benzofuro[3,2-d]pyrimidin-4-yl)piperazine-1-carbothioamide; MP-470; HPK56
-
DescriptionAmuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC₅₀ values of 10 nM, 40 nM and 81 nM, respectively. It also disrupts DNA repair likely through suppression of Homologous Recombination protein Rad51.
-
CAS Number850879-09-3
-
Structure AvailableYes
-
Molecular FormulaC₂₃H₂₁N₅O₃S
-
Molecular Weight447.51
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>30 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA multi-targeted tyrosine kinase inhibitor
-
Storage Condition-20°C
-
Shipping ConditionGel pack
-
Shelf Life36 months
-
PubChem CID11282283
-
SMILESC1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6
-
InChiInChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)
-
InChi KeyFOFDIMHVKGYHRU-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameAmuvatinib
-
Alternative nameAmuvatinib
-